Related Experiment Video
Updated: Jun 4, 2025

04:00
Author Spotlight: Assessing Surgical Frailty with Point-of-Care Ultrasound of Quadriceps Muscles
Published on: July 26, 2024
453
Frailty Status, Not Just Age, is Associated With Postoperative Opioid Consumption: A Retrospective, Population-based
Kyle R Latack1, Ryan Howard2,3,4, Mark C Bicket3,5
1From the Department of Obstetrics and Gynecology, University of Michigan, Ann Arbor, MI.
Summary
Frailty status is linked to higher postoperative opioid use in patients undergoing common surgeries. This finding suggests frailty should be considered in opioid prescribing guidelines and outcomes research.
Area of Science:
- Geriatric Medicine
- Surgical Outcomes
- Pain Management
Background:
- Physiologic reserve is a key factor in surgical recovery, assessed by age and frailty.
- While older age may correlate with lower opioid needs, frailty status is a distinct, understudied predictor of postoperative opioid consumption.
- Understanding frailty's impact is crucial for optimizing pain management and patient outcomes.
Purpose of the Study:
- To investigate the association between frailty status and postoperative opioid consumption.
- To determine if frailty influences opioid requirements independently of chronological age.
- To inform future pain management strategies and outcomes analyses.
Main Methods:
- Retrospective analysis of 34,854 opioid-naïve adult patients undergoing common surgical procedures (November 2017 - February 2021).
- Frailty assessed using the modified Frailty Index (mFi-5).
- Primary outcome: 30-day patient-reported opioid consumption (Oral Morphine Equivalents - OME); analyzed via linear regression, stratified by age.
Main Results:
- Patients with a modified Frailty Index score >1 reported significantly higher opioid consumption (3.3 OME greater; 95% CI = 1.5-5.1).
- This association persisted in patients over 65 years old (2.7 OME greater; 95% CI = 0.2-5.1).
- Higher frailty status was paradoxically linked to smaller discharge opioid prescriptions.
Conclusions:
- Frailty status is a significant predictor of increased opioid consumption following common surgical procedures.
- Incorporating frailty assessment into clinical practice can refine opioid prescribing and improve patient outcomes.
- Future research should consider frailty as a critical factor in analyzing opioid use and adverse events.
More Related Videos
Related Concept Videos
Opioid Analgesics: Synthetic and Semisynthetic Opioids
219
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
219
Opioid Analgesics: Morphine and Other Natural Cogeners
179
Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
179
Analgesia and Pain Management
496
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
496
Opioid Receptors: Overview
510
Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2,...
510

